Skip to main content

Table 1 Study exclusion and inclusion criteria

From: The EXPANd trial: effects of exercise and exploring neuroplastic changes in people with Parkinson’s disease: a study protocol for a double-blinded randomized controlled trial

Inclusion criteria

Exclusion criteria

- Idiopathic PD

- Hoehn & Yahr [25] scores 2 to 3

- Stable dose of anti-Parkinson’s medication for approximately 3 weeks

- ≥ 60 years of age

- Montreal Cognitive Assessment (MoCA) [26] score ≥ 21

- Ambulate indoors without mobility aid

- Balance impairments (≤27 on the Mini-BESTest)

- Any other existing disorder that may substantially influence balance performance, voice or speech performance or participation in the interventions

- Having participated in an intensive exercise program for balance or speech during the last six months

For imaging

- Pacemakers, deep brain stimulators or other MRI incompatible implants

- Claustrophobia

- Unilateral or bilateral blindness

- Inability to hear instructions without hearing aid

- Severe states of: diplopia, tremor, dyskinesia or dystonia